List of Tables
Table 1. Immune Cell Therapy Market Trends
Table 2. Immune Cell Therapy Market Drivers & Opportunity
Table 3. Immune Cell Therapy Market Challenges
Table 4. Immune Cell Therapy Market Restraints
Table 5. Global Immune Cell Therapy Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Immune Cell Therapy Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Immune Cell Therapy Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Immune Cell Therapy Product Type
Table 9. Key Companies Time to Begin Mass Production of Immune Cell Therapy
Table 10. Global Immune Cell Therapy Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immune Cell Therapy as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Immune Cell Therapy Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Immune Cell Therapy Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Immune Cell Therapy Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Immune Cell Therapy Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Immune Cell Therapy Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Immune Cell Therapy Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Immune Cell Therapy Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Immune Cell Therapy Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Immune Cell Therapy Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Immune Cell Therapy Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Immune Cell Therapy Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Immune Cell Therapy Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Immune Cell Therapy Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Immune Cell Therapy Sales Value by Region (2019-2024) & (%)
Table 27. Global Immune Cell Therapy Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Immune Cell Therapy Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Immune Cell Therapy Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Immune Cell Therapy Sales Value, (2025-2030) & (US$ Million)
Table 31. Adaptimmune Basic Information List
Table 32. Adaptimmune Description and Business Overview
Table 33. Adaptimmune Immune Cell Therapy Products, Services and Solutions
Table 34. Revenue (US$ Million) in Immune Cell Therapy Business of Adaptimmune (2019-2024)
Table 35. Adaptimmune Recent Developments
Table 36. Altor Bioscience Corporation Basic Information List
Table 37. Altor Bioscience Corporation Description and Business Overview
Table 38. Altor Bioscience Corporation Immune Cell Therapy Products, Services and Solutions
Table 39. Revenue (US$ Million) in Immune Cell Therapy Business of Altor Bioscience Corporation (2019-2024)
Table 40. Altor Bioscience Corporation Recent Developments
Table 41. Cellectis Basic Information List
Table 42. Cellectis Description and Business Overview
Table 43. Cellectis Immune Cell Therapy Products, Services and Solutions
Table 44. Revenue (US$ Million) in Immune Cell Therapy Business of Cellectis (2019-2024)
Table 45. Cellectis Recent Developments
Table 46. Juno Therapeutics Basic Information List
Table 47. Juno Therapeutics Description and Business Overview
Table 48. Juno Therapeutics Immune Cell Therapy Products, Services and Solutions
Table 49. Revenue (US$ Million) in Immune Cell Therapy Business of Juno Therapeutics (2019-2024)
Table 50. Juno Therapeutics Recent Developments
Table 51. Kite Pharma Basic Information List
Table 52. Kite Pharma Description and Business Overview
Table 53. Kite Pharma Immune Cell Therapy Products, Services and Solutions
Table 54. Revenue (US$ Million) in Immune Cell Therapy Business of Kite Pharma (2019-2024)
Table 55. Kite Pharma Recent Developments
Table 56. Novartis Basic Information List
Table 57. Novartis Description and Business Overview
Table 58. Novartis Immune Cell Therapy Products, Services and Solutions
Table 59. Revenue (US$ Million) in Immune Cell Therapy Business of Novartis (2019-2024)
Table 60. Novartis Recent Developments
Table 61. Takara Bio Basic Information List
Table 62. Takara Bio Description and Business Overview
Table 63. Takara Bio Immune Cell Therapy Products, Services and Solutions
Table 64. Revenue (US$ Million) in Immune Cell Therapy Business of Takara Bio (2019-2024)
Table 65. Takara Bio Recent Developments
Table 66. Unum Therapeutics Basic Information List
Table 67. Unum Therapeutics Description and Business Overview
Table 68. Unum Therapeutics Immune Cell Therapy Products, Services and Solutions
Table 69. Revenue (US$ Million) in Immune Cell Therapy Business of Unum Therapeutics (2019-2024)
Table 70. Unum Therapeutics Recent Developments
Table 71. Key Raw Materials Lists
Table 72. Raw Materials Key Suppliers Lists
Table 73. Immune Cell Therapy Downstream Customers
Table 74. Immune Cell Therapy Distributors List
Table 75. Research Programs/Design for This Report
Table 76. Key Data Information from Secondary Sources
Table 77. Key Data Information from Primary Sources
Table 78. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Immune Cell Therapy Product Picture
Figure 2. Global Immune Cell Therapy Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Immune Cell Therapy Sales Value (2019-2030) & (US$ Million)
Figure 4. Immune Cell Therapy Report Years Considered
Figure 5. Global Immune Cell Therapy Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Immune Cell Therapy Revenue in 2023
Figure 7. Immune Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. T Cell Therapy Picture
Figure 9. Natural Killer (NK) Cell Therapy Picture
Figure 10. Other Picture
Figure 11. Global Immune Cell Therapy Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 12. Global Immune Cell Therapy Sales Value Market Share by Type, 2023 & 2030
Figure 13. Product Picture of Stomach Cancer
Figure 14. Product Picture of Lung Cancer
Figure 15. Product Picture of Colorectal Cancer
Figure 16. Product Picture of Esophageal Cancer
Figure 17. Product Picture of Pancreatic Cancer
Figure 18. Product Picture of Other
Figure 19. Global Immune Cell Therapy Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 20. Global Immune Cell Therapy Sales Value Market Share by Application, 2023 & 2030
Figure 21. North America Immune Cell Therapy Sales Value (2019-2030) & (US$ Million)
Figure 22. North America Immune Cell Therapy Sales Value by Country (%), 2023 VS 2030
Figure 23. Europe Immune Cell Therapy Sales Value (2019-2030) & (US$ Million)
Figure 24. Europe Immune Cell Therapy Sales Value by Country (%), 2023 VS 2030
Figure 25. Asia Pacific Immune Cell Therapy Sales Value (2019-2030) & (US$ Million)
Figure 26. Asia Pacific Immune Cell Therapy Sales Value by Country (%), 2023 VS 2030
Figure 27. South America Immune Cell Therapy Sales Value (2019-2030) & (US$ Million)
Figure 28. South America Immune Cell Therapy Sales Value by Country (%), 2023 VS 2030
Figure 29. Middle East & Africa Immune Cell Therapy Sales Value (2019-2030) & (US$ Million)
Figure 30. Middle East & Africa Immune Cell Therapy Sales Value by Country (%), 2023 VS 2030
Figure 31. Key Countries/Regions Immune Cell Therapy Sales Value (%), (2019-2030)
Figure 32. United States Immune Cell Therapy Sales Value, (2019-2030) & (US$ Million)
Figure 33. United States Immune Cell Therapy Sales Value by Type (%), 2023 VS 2030
Figure 34. United States Immune Cell Therapy Sales Value by Application (%), 2023 VS 2030
Figure 35. Europe Immune Cell Therapy Sales Value, (2019-2030) & (US$ Million)
Figure 36. Europe Immune Cell Therapy Sales Value by Type (%), 2023 VS 2030
Figure 37. Europe Immune Cell Therapy Sales Value by Application (%), 2023 VS 2030
Figure 38. China Immune Cell Therapy Sales Value, (2019-2030) & (US$ Million)
Figure 39. China Immune Cell Therapy Sales Value by Type (%), 2023 VS 2030
Figure 40. China Immune Cell Therapy Sales Value by Application (%), 2023 VS 2030
Figure 41. Japan Immune Cell Therapy Sales Value, (2019-2030) & (US$ Million)
Figure 42. Japan Immune Cell Therapy Sales Value by Type (%), 2023 VS 2030
Figure 43. Japan Immune Cell Therapy Sales Value by Application (%), 2023 VS 2030
Figure 44. South Korea Immune Cell Therapy Sales Value, (2019-2030) & (US$ Million)
Figure 45. South Korea Immune Cell Therapy Sales Value by Type (%), 2023 VS 2030
Figure 46. South Korea Immune Cell Therapy Sales Value by Application (%), 2023 VS 2030
Figure 47. Southeast Asia Immune Cell Therapy Sales Value, (2019-2030) & (US$ Million)
Figure 48. Southeast Asia Immune Cell Therapy Sales Value by Type (%), 2023 VS 2030
Figure 49. Southeast Asia Immune Cell Therapy Sales Value by Application (%), 2023 VS 2030
Figure 50. India Immune Cell Therapy Sales Value, (2019-2030) & (US$ Million)
Figure 51. India Immune Cell Therapy Sales Value by Type (%), 2023 VS 2030
Figure 52. India Immune Cell Therapy Sales Value by Application (%), 2023 VS 2030
Figure 53. Immune Cell Therapy Industrial Chain
Figure 54. Immune Cell Therapy Manufacturing Cost Structure
Figure 55. Channels of Distribution (Direct Sales, and Distribution)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
